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The legacy
The legacy for the present Western Thoracic Surgical
Association began in the mid-1960s in Oakland,
California. A group of thoracic surgeons from the East
Bay and San Francisco began conducting monthly
meetings in the Alameda Contra Costa County Medical
Society offices to train residents in the delivery of sci-
entific papers. The group, originated by Dr Kenneth
Hardy, was known as the Bay Area Thoracic Surgical
Society. Dr Hardy was subsequently killed in an acci-
dent and the meetings were suspended.
In 1973, the records and bank account of the society,
totaling $500, were turned over to Dr David Dugan, and
a meeting of the members was organized to determine
the future of the society. These members met at Samuel
Merritt Hospital in Oakland on November 27, 1973. A
decision was made to continue the society and to
include chest surgeons from all of Northern California.
The name of the society was changed to the Northern
California Thoracic Surgical Society and officers were
elected: Dr David Dugan, president; Dr Arthur Thomas,
secretary/treasurer; and Dr Buford Burch of Martinez,
California, recorder. Dr Thomas was given the assign-
ment of writing the by-laws and constitution for the
society.
On December 11, 1973, the executive committee,
consisting of Drs Dugan, Thomas, and Burch, met again
at Samuel Merritt Hospital. At this meeting a decision
was made to change the name of the society to The
Samson Thoracic Surgical Society, this decision being
made unilaterally and without the knowledge or per-
mission of Dr Paul Samson. A decision was also made
to extend membership to thoracic surgeons throughout
all of California, and an inaugural dinner of the society
was organized.
Invitations were sent to 98 thoracic surgeons in
California on new stationery bearing the red and white
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Fig 1. The seal and letterhead of The Samson Thoracic
Surgical Society.
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seal of the society, the same seal anchoring the letter-
head of our stationery today (Fig 1). To everyone’s sur-
prise, 91 of 98 invitees accepted membership.
Notification of establishment of the society was final-
ly sent to Dr Samson on May 7, 1974, informing him
of the organization of this society that bore his name.
He received this notification, on stationery also bear-
ing his name and logo, while vacationing in Mexico
and accepted this honor, noting he was “deeply touched
and completely flabbergasted.”
The inaugural dinner was a gala affair held on June 8,
1974, at the Mark Hopkins Hotel in San Francisco and
attended by all 91 charter members of the society, as
well as invited guests. The guest speaker was Dr Lyman
Brewer, a lifelong friend and colleague of Dr Samson,
whose address was titled, “Thoracic Surgery Comes to
Alta, California.”1,2
Shortly thereafter, the executive committee of the
society met in San Francisco. The committee decided at
that time to extend the scope of membership in the soci-
ety to thoracic surgeons in the thirteen Western states
and the two Western Canadian provinces. Doing so
added an additional 124 members, bringing total mem-
bership to 215.
In November 1974, arrangements were made for the
first annual meeting. At the November meeting, Dr
Brian Blades, then-Editor of The Journal of Thoracic
and Cardiovascular Surgery, designated the Journal as
the official organ of The Samson Thoracic Surgical
Society. This designation appeared on the cover and an
acceptance editorial and a list of members appeared in
the contents of the Journal in January 1975. This mate-
rial was published before the first meeting of the soci-
ety. A special prize and honorarium was also offered to
the resident submitting the best abstract, that abstract
also to be presented at the annual meeting.
Dr Paul Samson was born in Emporia, Kansas, in
1905 (Fig 2). He acquired the nickname of “Buck”
from his huge size and physical prowess (standing 6
feet 6 inches) and his widely known competitiveness.
He graduated from the University of Michigan, where
he was a world-class swimmer and member of the
United States water polo team at the 1928 Olympics in
Amsterdam.
After graduation from medical school at the
University of Michigan, he served a general surgical
residency at Northwestern University in Chicago. He
returned to Michigan for his thoracic surgical training
under the tutelage of Dr John Alexander, a pioneer in
the surgical treatment of tuberculosis. He completed
his residency in 1935.
During World War II, he was actively engaged in the
surgical treatment of casualties in both the North
African and European theaters, performing the first
pneumonectomy in the foreign field. He coauthored,
with Dr Lyman Brewer, the text Forward Surgery of the
Severely Injured, documenting the treatment of more
than 10,000 battle casualties.
After the war, Dr Samson returned to Oakland and
began his practice of thoracic surgery, specializing in
the surgical treatment of tuberculosis and empyema.
He achieved numerous honors during his illustrious
career, including president of The American Associa-
tion for Thoracic Surgery, the first president of The
Society of Thoracic Surgeons, and membership on both
the American Board of Thoracic Surgery and the Board
of Regents of the American College of Surgeons.
The first meeting of The Samson Thoracic Surgical
Society was held May 28 to 30, 1975, at the Biltmore
Hotel in Santa Barbara, California. The first paper pre-
sented at that meeting, “Prosthetic Replacement of the
Aortic Arch,” was delivered by Dr Randall Griepp.3 Dr
William Brody, then at the National Institutes of Health
and current president of the Johns Hopkins University,
was the first resident prize essayist, presenting a paper
titled, “Long-Term Morphologic and Hemodynamic
Evaluation of the Left Ventricle After Cardiopulmonary
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Fig 2. Paul C. Samson, MD (1905-1982).
Bypass: A Comparison of Normothermic Anoxic
Arrest, Coronary Artery Perfusion, and Profound
Topical Cardiac Hypothermia.”4 We are pleased to have
Dr Brody at this meeting, representing all of the previ-
ous resident essayists.
In his book The Prophet, Kahlil Gibran5 talks about
giving, stating, “It is when you give of yourself that you
truly give.” The creation of The Samson Thoracic
Surgical Society was truly a labor of love of a few giv-
ing individuals, specifically, David Dugan and Arthur
Thomas, that rapidly spread throughout the society. Dr
Dugan, in his presidential address before the society in
1977, stated, “The Samson Thoracic Surgical Society
is an infant, delivered spontaneously and with a future
of its own making.”6
Since its inception, and using this first meeting as a
template, the society, later to become The Western
Thoracic Surgical Association, has grown from its
regional roots to become a society of national and inter-
national prowess. We now celebrate its silver anniver-
sary, which provides us an opportunity to cite historic
landmarks reached along the way, reflect on the words
and achievements of those providing leadership in the
past, and to use their accomplishments as teaching
tools as we face ever-mounting challenges in cardiac
and thoracic surgery entering the new millennium.
As stated earlier, the name of the society was
changed shortly after Dr Samson’s death in 1982. Dr
David Dugan recalled,
Later, when it became obvious that our STSS, in order
to be recognized by the ACS and listed by the American
College of Surgeons, had to change the name because
they didn’t accept name societies. One day, Paul and I
were going over to the San Francisco Surgical, and I was
driving. I said to him, “You know, Paul, we are going to
have to change the name of our society.” He replied,
“Never, not as long as I live you won’t change it.” I said,
“Okay, 20 minutes after you die, we’re changing it.” He
said, “Okay, that’s fine.” Actually, that is what happened.*
At the annual business meeting in June 1983, a unan-
imous vote by the membership mandated a change of
the name of The Samson Thoracic Surgical Society to
The Western Thoracic Surgical Association. This was
officially accomplished in October 1984.
Members of the WTSA have served in leadership
capacities in our society, as well as in national leader-
ship roles. Five members of the WTSA have served as
president of The American Association for Thoracic
Surgery, and nine honorary members have served in
that capacity. Ten past presidents and one president
elect of The Society of Thoracic Surgeons have come
from the WTSA, and another four are honorary mem-
bers of our society.
The Samson Resident Prize Essay Award was initi-
ated at the first meeting in Santa Barbara and has been
a mainstay of each annual meeting since that time.
Some of these papers, such as that delivered by Dr
David E. Hansen from Stanford in 1986, titled
“Relative Contributions of the Anterior and Posterior
Mitral Chordae Tendineae to Global Left Ventricular
Systolic Function,” have made monumental advances
in understanding the pathophysiology of specific car-
diac and thoracic disorders and altering the treatment
regimen based on this new knowledge.7
We have enjoyed the leadership of fine presidents,
beginning with Dr David Dugan and extending through
my predecessor, Dr Win Wells. Their words of wisdom,
inscripted in their presidential addresses, have provid-
ed us with historical, clinical, and philosophical treatis-
es pertaining to our specialty, citing where we have
been, where we are, and where we should be in the
future.
Dr Dugan chronicled the origin of our organization in
his initial presidential address, titled, “The Birth of a
Society.” He stated, “This has started what we hope
will be a fine surgical society... . Now the decisions
for furtherance of this society will be up to the orga-
nization.”6
Dr John Connolly addressed the largest gathering
of the society in Coronado in 1978, outlining “The
History of Coronary Artery Surgery.” In this presenta-
tion, he cited my mentor, Dr David C. Sabiston, Jr, for
his early pioneering work in coronary artery bypass.8
My friend and colleague, Dr Harold Liddle, present-
ed a beautiful address on the “Perspectives in Coronary
Artery Surgery,” outlining an extensive and thorough
evaluation of patients having undergone coronary
artery bypass.9
Dr Burt Meyer gave an overview of 30 years of tho-
racic surgery, predicting revolutionary changes in sur-
gical technology. I especially enjoyed the last para-
graph of his manuscript, which states: “I wanted to
recognize the contributions of those physicians who
were pioneers in this surgical specialty by appending a
thorough reference list. However, after poring over the
journals, I realize that their place in history has been
long established. They have been listed in the bibli-
ographies of many manuscripts more distinguished
than this one.”10
I believe the most profound address was delivered by
Dr Robert Jamplis in 1983 at the meeting in Colorado
Springs. In his treatise, titled “From Whence and
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Whither To,” he stated: “In my opinion, a revolution is
occurring in health care in the United States, and the
barn is burning. It will profoundly affect the lives of all
doctors of medicine and will not exempt thoracic sur-
geons in particular.” He goes on to talk about factors
contributing to this problem, citing advances in medical
technology, the “graying of America” due to people liv-
ing longer, and defensive medicine.11
Dr Jamplis goes on to state: “Our greatest failure has
been our devotion to the status quo. No matter how nos-
talgic we feel about it, it is no longer a viable entity. I
truly believe we now have only one more chance to
lead the revolution or be consumed by it—take charge
or be taken over.” These are certainly words of wisdom
and accurate predictions of subsequent events that have
transpired.
We have been taught the experimental basis for car-
diac transplantation by the world’s leading pioneer in
the field. We have been educated on the intricacies of
peer review, the pitfalls in medical education and resi-
dency training, the renaissance in thoracic surgery, and
the anatomy and pathophysiology of the mitral valve by
experts in their respective fields. We have been warned
of the assault on our specialty from outside forces, and
the decade by decade changes that have occurred in
cardiothoracic surgery have been chronicled. We have
even had a chance to dream: “If I Were King.”12
By those who created and have led the society for the
past quarter of a century, we have been educated, coun-
seled, warned, and taught by example the tools we must
master if we are to excel in the practice of cardiotho-
racic surgery.
The challenge
Our challenge in entering the new millennium is to
use these teachings and to overcome the many obsta-
cles we now face and will encounter in the future. Sir
Winston Churchill said, “The farther backward you can
look, the farther forward you are likely to see.”13
The basic philosophy and foundation of medical care
has not changed over these many years. In a valedicto-
ry address given before the University of Pennsylvania
Medical School graduating class in 1889, Sir William
Osler related his deep reverence for his profession and
the physician-patient relationship and cited three great
lessons of life:
Learn to consume your own smoke with an extra
draught of hard work, so that those about you may not be
annoyed with the dust and dirt of your complaints... . We
are not here to get all we can out of life for ourselves, but
to try to make the lives of others happier... . The practice
of medicine is an art, not a trade: a calling not a business:
a calling in which your heart will be used equally with
your head... . The third lesson you may find the hardest
of all—that the law of higher life is only fulfilled by
love, i.e. charity.*
I believe we still consider the practice of medicine,
including surgery, to be a privilege to all of us. We have
a profession to which we are dedicated, which carries
with it the responsibility of care of our fellowman.
Although this philosophical foundation has remained
stable, the delivery of the final product has been ever
changing. In his presidential address to this society in
1991, Dr Richard Anderson talked of “Change and
Thoracic Surgery,” citing the 1960s as a decade of
innovation, the 1970s as a decade of clinical expansion,
and the 1980s as a decade of increasing restraints.14
I would append Dr Anderson’s treatise, adding the
1990s as a decade of dichotomy. Never before have we
been given such elaborate and highly technical diag-
nostic and therapeutic modalities, while being
squeezed ever tighter by those who pay the bills.
Compounding this, we are faced with an ever aging
population. The graying of America, referred to by Dr
Jamplis, has become even more pronounced.
We are being bombarded by new technical advances
at an unprecedented explosive rate. We now have the
options of MIDCAB, OPCAB, Port-Access, and vari-
ous other minimally invasive surgical approaches.
Aortic and mitral homografts, aortic root homografts,
and stentless heterografts are now available. Trans-
myocardial revascularization and gene therapy as
means of stimulating angiogenesis are here or on the
horizon. Mechanical cardiac assist devices using right,
left, or biventricular support, as well as totally
implantable hearts, are now on the shelves of most
major medical centers. Surgical treatment of electro-
physiologic pathology, such as use of the maze proce-
dure in patients with symptomatic atrial fibrillation,
now has clinical applicability.
Our cardiology colleagues are also experiencing
tremendous technical advances in interventional tech-
niques—multivessel angioplastic procedures, rotation-
al atherectomy, and the use of stents containing as
many additives as ingredients we have proposed for
cardioplegic solutions over the years. Percutaneous
valvuloplasty, percutaneous myocardial revasculariza-
tion, gene therapy, ablative procedures, and implant-
able defibrillators are here or on their way.
The selection of surgical candidates from the total
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patient pool has become ever more challenging. The
number of patients potentially eligible for use of this
vast new technology is expanding because of the ever
aging patient population. Further compounding the
dilemma are those patients having had at least one pre-
vious cardiothoracic surgical procedure; those with
impaired ventricular function; end-organ disease, such
as renal, respiratory, and/or hepatic insufficiency; cere-
brovascular and peripheral vascular insufficiency; and
diabetes mellitus. Our decision making must be tem-
pered by Dr Alfred Blalock’s observation years ago:
“The fact that a patient could die does not necessarily
mean he should be operated upon.”15
We are looked on as the last bastion of hope for treat-
ment of these patients, while, at the same time, we are
being scrutinized as never before by survival statistics,
published and available to the public in some states,
which have questionable risk stratification modifica-
tions.
Obviously, this new and advanced technology, as
impressive and, in many instances, beneficial as it may
be, carries with it an enormous price tag. Many of the
new technologies are and will be shown to be cost
effective, as well as beneficial to the patient, and should
be retained. Others will not be beneficial and should be
discarded.
In his same presidential address, Dr Robert Jamplis
stated:
When we allowed our profession to become the num-
ber one industry in the United States (over $300 billion
dollars annually, dwarfing even the budget for the
Department of Defense), when we allowed ourselves to
become more than 10% of the gross national product,
and when we were complacent in allowing third-party
payers to escalate health care costs to astronomical
heights, we inadvertently but most definitely set the
stage for the revolution—a revolution that will greatly
affect the public, our patients, as well.*
The percent of the gross domestic product spent on
health care in the United States in 1960 was 5.1%. This
has continuously escalated to 13.9% in 1998 and is pro-
jected to rise to 16.8% by the year 200516 (Fig 3). An
even more astonishing fact is that pharmaceutical costs,
as a percent of total medical expense, have risen from
7.3% in 1984 to 18% in 1998.17 The average cost
nationwide of coronary artery bypass in 1991 was
$38,414 and in 1997, only six years later, it had risen to
$50,420.18
Concomitantly, we are faced by ever compressing
payment from third-party managed care providers, who
have taken over the decision making in reimbursement
for health care delivery. Ten years ago, in areas of high
managed care penetration, their reimbursement for hos-
pitals was 15% above total cost of a specific procedure.
This surplus was used for education, research, payment
of bad debts, and money to shareholders in for-profit
companies. Now this reimbursement is 2% below total
cost. The tail is wagging the dog because we, as car-
diothoracic surgeons, have shown little ability, care, or
concern to be selective in adopting and implementing
from the vast cupboard of new technology those proce-
dures and techniques that will be cost effective and
beneficial to the patient.
We and our cardiology colleagues have shown no
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interest in sitting down together to mutually solve this
problem. We should have learned from our experiences
in the 1980s that we must take a more active role in the
control of our destiny. The cardiologists are presently
experiencing their “golden years.” They must be con-
vinced by us that this honeymoon will soon end and that
only through cooperative efforts will it be possible to
regain control of health care delivery in cardiovascular
disease. The ultimate benefactor would be, and should
be, our patients. In my opinion, the present situation is
doomed to failure. Santayana is quoted as saying,
“Those who cannot remember the past are condemned
to repeat it.” Bob Jamplis’s barn has now burned. It has
been replaced by a smaller barn that is now on fire, the
arsonists being the infusion of this new technology
compounded by shrinkage in payments from third-party
carriers and our inability to scrutinize and be selective.
Our avenue of escape from this dilemma lies in coop-
eration rather than competition. We must again put the
patient at the apex of our treatment strategy plan. This
can only be done through a cooperative effort of car-
diothoracic surgeons and cardiologists determining
what is right for the patient, assessing such factors as
risk, time in the hospital, time away from work, cos-
metic result, pain, long-term benefit, and cost.
I believe this can best be achieved through a horizon-
tal network of health care delivery for cardiovascular
services, consisting of surgeons, cardiologists, nurses,
and administrators, networking with other health care
providers and all working together to deliver the final
product, which would address all of the above factors
(Fig 4). At LDS Hospital in Salt Lake City, we have
such an integrated organization, and we have been very
impressed with its benefits. Only with such a model can
maximum cooperation among all health care providers
lead to cost savings, efficiency, and better patient sur-
vival. Through this type of model, we as physicians
could regain a foothold on health care contract negotia-
tion and the ultimate benefactor would be our patients.
Dr David Dugan, in his presidential address to The
American Association for Thoracic Surgery in 1977
titled, “Assured Survival,” stated: “Let us try to put our-
selves back on the pedestal of self-respect, not that we
are better than our fellowman, but that we are privi-
leged to help him in his time of difficulty. We see him
at his worst. May we always give him our best.”19 In his
1975 address he stated: “We are dependent on the
youth in our specialty to carry on the responsible work
in maintaining an association of high professional qual-
ity, social interchange, and unquestioned academic
stature.”6
It is my hope and challenge that we will use the legacy
provided us by the namesake, founders, and senior
members of this association to confront the challenge
before us in the new millennium. I hope that the present
and future leaders of this society will use this council
and will be the pioneers in implementing new strategies
for combating the tremendous problems presently fac-
ing us in delivery of health care to patients with car-
diovascular disease.
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